Article
From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers.
Expert review of molecular diagnostics - 1 Jan 2024
Hannani Monica T, Thudium Christian S, Karsdal Morten A, Ladel Christoph, Mobasheri Ali, Uebelhoer Melanie, Larkin Jonathan, Bacardit Jaume, Struglics André, Bay-Jensen Anne-Christine
Abstract excerpt
INTRODUCTION: Osteoarthritis (OA) affects over 500 million people worldwide. OA patients are symptomatically treated, and current therapies exhibit marginal efficacy and frequently carry safety-risks associated with chronic use. No disease-modifying therapies have been approved to date leaving surgical joint replacement as a last resort. To enable effective patient care and successful drug development there is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
